CN103223153B - Medicament for treating femoral head necrosis - Google Patents
Medicament for treating femoral head necrosis Download PDFInfo
- Publication number
- CN103223153B CN103223153B CN201310184822.5A CN201310184822A CN103223153B CN 103223153 B CN103223153 B CN 103223153B CN 201310184822 A CN201310184822 A CN 201310184822A CN 103223153 B CN103223153 B CN 103223153B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating femoral head necrosis, which is prepared from the following components in certain parts by weight: figwort, cornel, Acorus gramineus, ephedra, clove, saururus chinensis, red tangerine peel, rhizoma sparganii, rhubarb, Chinese holly, eupatorium, rhizoma anemarrhenae, tuckahoe, dried orange peel, moutan bark, coltsfoot flower, kudzu root, heracleum hemsleyanum michaux, Rhizoma Zedoariae, selfheal, dark plum, root bark of white mulberry, myrrh, Curculigo orchioides, folium artemisiae argyi, lychee seed, Rhodiola rosea, acanthopanax bark, rangooncreeper fruit, emblic leafflower fruit, Fructus Forsythiae, immature bitter orange, rhizoma alismatis, gromwell, Ligotidis Herba, Phytolacca acinosa, rose, magnolia flower, Herba Polygalae Japonicae, radix sileris, dried ginger, Folium Turpiniae, murraya jasminorage, rhizoma arisaematis, rhizoma pleionis, morinda root, pomegranate rind, morning glory seed, gerba pyrolae and marsdeniae tenacissimae caulis. The medicament provided by the invention has the advantages of accessible raw materials and exact curative effect; and tests prove that the medicament is high in effective rate and low in cost.
Description
Technical field
The present invention relates to Orthopeadic Surgery field, relate in particular to a kind of medicine for the treatment of femur head necrosis.
Background technology
Femur head necrosis is the generally acknowledged difficult disease of world's orthopaedics, and its serious harm mankind's health, gently makes people disable, heavy people is paralysed, and loses work and self care ability.The cause of disease that generally believes femur head necrosis mainly contains: wound, hormone, excessive drinking or osteoporosis etc.Main clinic symptoms is pain and marrow joint movement function obstacle.For this disease, mainly take conservative treatment, late period to adopt artificial replacement's art early stage.
Though have the scheme interview of multiple treatment femur head necrosis at present, but exist in various degree the shortcomings such as cost is high, the course for the treatment of is long, side effect is large, curative effect is undesirable
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of femur head necrosis.
In order to realize object of the present invention, the invention provides a kind of medicine for the treatment of femur head necrosis, it is to be made up of the material of following weight parts: 80 parts of Radix Scrophulariaes, 80 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts, Herba Ephedrae, 8 parts of Flos Caryophyllis, 65 parts of Rhizoma Saururi (Herba Saururi)s, 13 parts of Exocarpium Citri Rubrums, 30 parts of Rhizoma Sparganii, 5 parts of Radix Et Rhizoma Rhei, 65 parts of Ilex purpurea Hassk.[I.chinensis Sims, 15 parts of Herba Eupatoriis, 65 parts of the Rhizoma Anemarrhenaes, 40 parts, Poria, 20 parts of Pericarpium Citri Reticulataes, 80 parts of Cortex Moutans, 15 parts of Flos Farfaraees, 20 parts of Radix Puerariaes, 80 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Fructus Mumes, 30 parts of Cortex Mori, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 65 parts of Semen Litchis, 65 parts of Radix Rhodiolaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 65 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 80 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 80 parts of Radix Phytolaccaes, 80 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 80 parts of Herba Polygalae Japonicae, 65 parts of Radix Saposhnikoviaes, 65 parts of Rhizoma Zingiberiss, 80 parts of leaf of Turpinia pomifera (Roxb) D O., 45 parts of Folium Et Cacumen Murrayae, 60 parts of Rhizoma Arisaematiss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Preferably, medicine of the present invention can be made tablet, dispersible tablet, capsule or powder.
Raw material of the present invention is easy to get, determined curative effect, and high through evidence effective percentage, cost is low.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get 80 grams of Radix Scrophulariaes, 80 grams of Fructus Corni, 20 grams of Rhizoma Acori Graminei, 20 grams, Herba Ephedrae, 8 grams of Flos Caryophyllis, 65 grams of Rhizoma Saururi (Herba Saururi)s, 13 grams of Exocarpium Citri Rubrums, 30 grams of Rhizoma Sparganii, 5 grams of Radix Et Rhizoma Rhei, 65 grams of Ilex purpurea Hassk.[I.chinensis Sims, 15 grams of Herba Eupatoriis, 65 grams of the Rhizoma Anemarrhenaes, 40 grams, Poria, 20 grams of Pericarpium Citri Reticulataes, 80 grams of Cortex Moutans, 15 grams of Flos Farfaraees, 20 grams of Radix Puerariaes, 80 grams of Radix Angelicae Pubescentiss, 15 grams of Rhizoma Curcumae, 30 grams of Spica Prunellaes, 15 grams of Fructus Mumes, 30 grams of Cortex Mori, 20 grams of Myrrhas, 15 grams of Rhizoma Curculiginises, 35 grams of Folium Artemisiae Argyis, 65 grams of Semen Litchis, 65 grams of Radix Rhodiolaes, 26 grams of Cortex Acanthopanciss, 15 grams of Fructus Quisqualis, 65 grams of Fructus Phyllanthis, 30 grams of Fructus Forsythiaes, 15 grams of Fructus Aurantii Immaturuss, 30 grams of Rhizoma Alismatis, 80 grams of Radix Arnebiae (Radix Lithospermi)s, 5 grams of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 80 grams of Radix Phytolaccaes, 80 grams of Flos Rosae Rugosaes, 20 grams of Flos Magnoliaes, 80 grams of Herba Polygalae Japonicae, 65 grams of Radix Saposhnikoviaes, 65 grams of Rhizoma Zingiberiss, 80 grams of leaf of Turpinia pomifera (Roxb) D O., 45 grams of Folium Et Cacumen Murrayae, 60 grams of Rhizoma Arisaematiss, 50 grams of Pseudobulbus Cremastrae Seu Pleioness, 50 grams of Radix Morindae Officinaliss, 70 grams of Pericarpium Granatis, 40 grams of Semen Pharbitidiss, 50 grams of 35 grams of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes, pulverize, and crosses 100 mesh sieves, then adds 350 grams of sucrose, mixes, and packs in 100 bags and get final product.
Experimental example
One, patient's data
Treat 60 examples, wherein male 30 examples, female's 30 examples, the oldest 55 years old, minimum 31 years old, 45 years old mean age.Diagnostic criteria with reference to State Administration of Traditional Chinese Medicine issue " disease of tcm Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect [S]. Nanjing: publishing house of Nanjing University, 1994:193-195) formulate: 1. have obvious hip trauma history; 2. there is Long-term Hormone, excessive drinking history etc. without hip trauma history; 3. hip pain, take adductor starting point place as main, pain can be persistence or intermittence, and radiating pain is to knee joint downwards; 4. difficulty in walking, is the row of crossing mountains, and carrying out property increases the weight of; 5. hip joint function obstacle, is limited as master with inward turning abduction, and passive activity hip joint can have surrounding tissue cramp; 6. x-ray is taken the photograph the collapse of the femoral head of the visible femoral head density change of sheet inspection and middle and late stage.
Two, Therapeutic Method
Treat with the powder making in embodiment 1, wherein one day 2 times, each one bag 10 days is 1 course for the treatment of.Inactive other drug during treatment.
Three, efficacy assessment standard
Recovery from illness: walking is without the row of crossing mountains, and hip joint is without pain, lower limb are without secondary cripetura, and function is recovered completely or substantially, and X-ray film femoral head sequestrum district subsides, osteonecrosis and bone regeneration hardening phenomenon disappear substantially; Take a turn for the better: symptom alleviates, hip joint movable function improves, and lower limb cripetura is in 1cm left and right, and it is large or flat that X-ray film femoral head becomes, but osteonecrosis and bone regeneration hardening phenomenon are improved; Invalid: symptom is without improvement, and X-ray film sign is without improvement.
Four, result
Through the treatment of a course for the treatment of, 60 routine patients walk without the row of crossing mountains, and hip joint is without pain, and lower limb are without secondary cripetura, and function is recovered completely or substantially, and X-ray film femoral head sequestrum district subsides, osteonecrosis and bone regeneration hardening phenomenon disappear substantially, and therapeutic effect is recovery from illness.In therapeutic process, carry out tracing observation for 60 routine patients, do not find obvious untoward reaction.
Claims (1)
1. treat a medicine for femur head necrosis, it is characterized in that it is to be made up of the material of following weight parts: 80 parts of Radix Scrophulariaes, 80 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts, Herba Ephedrae, 8 parts of Flos Caryophyllis, 65 parts of Rhizoma Saururi (Herba Saururi)s, 13 parts of Exocarpium Citri Rubrums, 30 parts of Rhizoma Sparganii, 5 parts of Radix Et Rhizoma Rhei, 65 parts of Ilex purpurea Hassk.[I.chinensis Sims, 15 parts of Herba Eupatoriis, 65 parts of the Rhizoma Anemarrhenaes, 40 parts, Poria, 20 parts of Pericarpium Citri Reticulataes, 80 parts of Cortex Moutans, 15 parts of Flos Farfaraees, 20 parts of Radix Puerariaes, 80 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Fructus Mumes, 30 parts of Cortex Mori, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 65 parts of Semen Litchis, 65 parts of Radix Rhodiolaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 65 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 80 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 80 parts of Radix Phytolaccaes, 80 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 80 parts of Herba Polygalae Japonicae, 65 parts of Radix Saposhnikoviaes, 65 parts of Rhizoma Zingiberiss, 80 parts of leaf of Turpinia pomifera (Roxb) D O., 45 parts of Folium Et Cacumen Murrayae, 60 parts of Rhizoma Arisaematiss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310184822.5A CN103223153B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating femoral head necrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310184822.5A CN103223153B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating femoral head necrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103223153A CN103223153A (en) | 2013-07-31 |
| CN103223153B true CN103223153B (en) | 2014-07-09 |
Family
ID=48833949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310184822.5A Expired - Fee Related CN103223153B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating femoral head necrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103223153B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
| CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
| CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
| CN103285355B (en) * | 2013-06-14 | 2015-05-13 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN104306444A (en) * | 2014-11-04 | 2015-01-28 | 张华� | Traditional Chinese medicine for curing liver-kidney asthenia femoral head necrosis and preparation method thereof |
| CN105727239A (en) * | 2016-04-01 | 2016-07-06 | 王述伟 | Medicine for treating femoral head necrosis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015638A (en) * | 2007-02-15 | 2007-08-15 | 安徽科宝生物工程有限公司 | Bone recovering plaster |
| CN101361897A (en) * | 2008-09-18 | 2009-02-11 | 李爱英 | Traditional Chinese medicine for treating femur head necrosis |
-
2013
- 2013-05-20 CN CN201310184822.5A patent/CN103223153B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015638A (en) * | 2007-02-15 | 2007-08-15 | 安徽科宝生物工程有限公司 | Bone recovering plaster |
| CN101361897A (en) * | 2008-09-18 | 2009-02-11 | 李爱英 | Traditional Chinese medicine for treating femur head necrosis |
Non-Patent Citations (2)
| Title |
|---|
| 季春明等.股骨头坏死的中医药研究进展.《中医药学报》.2005,第33卷(第5期),57-58. |
| 股骨头坏死的中医药研究进展;季春明等;《中医药学报》;20050831;第33卷(第5期);57-58 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103223153A (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103223153B (en) | Medicament for treating femoral head necrosis | |
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN102379941B (en) | A kind of compound Chinese medicinal preparation treating fracture and preparation method thereof | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101607022B (en) | Chinese medicament bone-knitting pellet preparation | |
| CN103566278B (en) | Cortex torricelliae tiliifoliae | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN104474473A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof | |
| CN103784667A (en) | Externally-used Chinese herbal medicine liquor for treating rheumatoidbone disease and preparation and usage method thereof | |
| CN103239700A (en) | Medicament for treating rheumatism | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN101897928B (en) | Medicinal composition for treating ankylosing spondylitis and preparation method | |
| CN102600430B (en) | Medicine for curing femoral head necrosis | |
| CN102772617B (en) | Medicine for treating disease of hyperosteogeny | |
| CN105395867A (en) | Traditional Chinese medicine bone-joining elixir for treating fracture and preparation method of traditional Chinese medicine bone-joining elixir | |
| CN103157084A (en) | Drug for treating osteoporosis | |
| CN103585457A (en) | Medicament for treating bone fracture | |
| CN103041349B (en) | Decoction for treating femoral head necrosis | |
| CN102283942A (en) | Orally-administrated Chinese medicinal preparation for treating ankylosing spondlitis | |
| CN101843827B (en) | Chinese medicament for treating gout | |
| CN106109826B (en) | A kind of drug for treating caput femoris necrosis | |
| CN104274774A (en) | Traditional Chinese medicine composition for treating qi-stagnation blood-stasis type endometriosis | |
| CN103157085A (en) | Drug for treating fracture | |
| CN104825802A (en) | TCM (traditional Chinese medicine) composition for promoting healing after internal fixation of femoral neck fracture and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140709 Termination date: 20150520 |
|
| EXPY | Termination of patent right or utility model |